Published in J Virol on January 01, 1997
Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis. Microbiol Mol Biol Rev (2002) 1.20
Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes. Retrovirology (2004) 1.17
Nuclear targeting determinants of the far upstream element binding protein, a c-myc transcription factor. Nucleic Acids Res (2000) 1.14
NoD: a Nucleolar localization sequence detector for eukaryotic and viral proteins. BMC Bioinformatics (2011) 1.06
Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression. Front Biosci (2004) 1.05
Oncoviral bovine leukemia virus G4 and human T-cell leukemia virus type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate synthetase. J Virol (2002) 1.04
Subcellular localization of the bovine leukemia virus R3 and G4 accessory proteins. J Virol (2002) 0.97
Human endogenous retrovirus HERV-K(HML-2) encodes a stable signal peptide with biological properties distinct from Rec. Retrovirology (2009) 0.93
Molecular determinants of human T-lymphotropic virus type 1 transmission and spread. Viruses (2011) 0.92
The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth. Cell Death Differ (2005) 0.91
Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II sensitizes Jurkat T cells to Ras-mediated apoptosis. J Virol (2005) 0.90
HTLV-1 and HTLV-2: highly similar viruses with distinct oncogenic properties. Front Microbiol (2014) 0.89
Multimer formation is not essential for nuclear export of human T-cell leukemia virus type 1 Rex trans-activator protein. J Virol (1998) 0.88
Converging strategies in expression of human complex retroviruses. Viruses (2011) 0.86
The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle. Front Microbiol (2013) 0.85
Nuclear export and expression of human T-cell leukemia virus type 1 tax/rex mRNA are RxRE/Rex dependent. J Virol (2012) 0.84
HTLV-1 p30II: selective repressor of gene expression. Retrovirology (2004) 0.76
Expression of Alternatively Spliced Human T-Cell Leukemia Virus Type 1 mRNAs Is Influenced by Mitosis and by a Novel cis-Acting Regulatory Sequence. J Virol (2015) 0.76
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A (1985) 68.48
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (1988) 52.71
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1980) 30.08
Nuclear targeting sequences--a consensus? Trends Biochem Sci (1991) 16.65
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet (1985) 13.47
Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A (1981) 11.92
Primary structure of the Aequorea victoria green-fluorescent protein. Gene (1992) 11.16
HTLV-I associated myelopathy, a new clinical entity. Lancet (1986) 10.49
Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell (1991) 9.96
Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol (1990) 5.64
How proteins enter the nucleus. Cell (1991) 5.63
Expression and characterization of the trans-activator of HTLV-III/LAV virus. Science (1986) 5.15
Inhibition of RNA synthesis by actinomycin D: characteristic dose-response of different RNA species. J Cell Physiol (1970) 3.98
Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing. Cell (1988) 3.92
Structural and functional characterization of human immunodeficiency virus tat protein. J Virol (1989) 3.57
Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J (1988) 3.45
Chimeric green fluorescent protein as a tool for visualizing subcellular organelles in living cells. Curr Biol (1995) 3.44
Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J Virol (1992) 3.44
p27x-III and p21x-III, proteins encoded by the pX sequence of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A (1985) 3.34
The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev (1994) 3.34
Human adult T-cell leukemia virus: molecular cloning of the provirus DNA and the unique terminal structure. Proc Natl Acad Sci U S A (1982) 3.19
Subcellular localization of the human immunodeficiency virus trans-acting art gene product. J Virol (1988) 2.64
Mechanisms of nuclear protein import. Curr Opin Cell Biol (1995) 2.56
Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I. J Virol (1992) 2.52
Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif. J Virol (1991) 2.41
Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J Virol (1991) 2.30
Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J Virol (1991) 2.26
Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. Proc Natl Acad Sci U S A (1992) 2.20
Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood (1995) 2.19
Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells. Nucleic Acids Res (1990) 2.14
Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc Natl Acad Sci U S A (1992) 2.05
A single species of pX mRNA of human T-cell leukemia virus type I encodes trans-activator p40x and two other phosphoproteins. J Virol (1986) 2.04
Different sites of interaction for Rev, Tev, and Rex proteins within the Rev-responsive element of human immunodeficiency virus type 1. J Virol (1990) 1.90
Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization. J Virol (1990) 1.89
The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J Virol (1993) 1.77
The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements. Proc Natl Acad Sci U S A (1991) 1.68
The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments. Mol Cell Biol (1994) 1.67
Nucleolar targeting signal of human T-cell leukemia virus type I rex-encoded protein is essential for cytoplasmic accumulation of unspliced viral mRNA. Proc Natl Acad Sci U S A (1989) 1.59
HIV-1 Rev is capable of shuttling between the nucleus and cytoplasm. Virology (1994) 1.45
Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. J Virol (1993) 1.45
Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells. J Virol (1995) 1.37
Binding of trans-dominant mutant Rev protein of human immunodeficiency virus type 1 to the cis-acting Rev-responsive element does not affect the fate of viral mRNA. New Biol (1990) 1.37
Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology (1995) 1.20
Intracellular trafficking of the human immunodeficiency virus type 1 Rev protein: involvement of continued rRNA synthesis in nuclear retention. AIDS Res Hum Retroviruses (1995) 1.19
HTLV-1 gene expression by defective proviruses in an infected T-cell line. Virology (1993) 1.05
Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: implications for trans dominance. J Virol (1992) 1.01
A novel alternatively spliced viral mRNA transcribed in cells infected with human T cell leukemia virus type 1 is mainly responsible for expressing p21X protein. FEBS Lett (1991) 0.96
Reexamination of the coding potential of the HTLV-1 pX region. Virology (1992) 0.87
Nucleo-cytoplasmic redistribution of the HTLV-I Rex protein: alterations by coexpression of the HTLV-I p21x protein. Virology (1996) 0.85
The post-transcriptional regulator Rex of the human T-cell leukemia virus type I is present as nucleolar speckles in infected cells. Exp Cell Res (1995) 0.83
The open reading frame I (ORF I)/ORF II part of the human T-cell leukemia virus type I X region is dispensable for p40tax, p27rex, or envelope expression. J Virol (1994) 0.83
p21rex protein of HTLV-1. J Acquir Immune Defic Syndr (1990) 0.77
Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med (1995) 2.75
CD4: CD8 ratio and HIV infection: the "tap-and-drain' hypothesis. Immunol Today (1996) 2.19
Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection. AIDS (1991) 1.97
B-cell activation and HIV-1 infection: deeds and misdeeds. Immunol Today (1990) 1.95
HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. J Immunol (1989) 1.66
Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes. J Infect Dis (2000) 1.57
Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitals. Vigil'Roc Study Group. J Antimicrob Chemother (1993) 1.50
Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. J Immunol (1990) 1.47
Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation. Leukemia (2003) 1.40
Solution structure of oxidized horse heart cytochrome c. Biochemistry (1997) 1.39
Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I). Oncogene (1999) 1.34
Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein. J Virol (2001) 1.33
Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects. Clin Immunol Immunopathol (1988) 1.30
In-vitro production of HIV-specific antibody in children at risk of AIDS. Lancet (1988) 1.22
Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. J Clin Invest (1996) 1.20
Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology (1995) 1.20
Magnetic susceptibility tensor anisotropies for a lanthanide ion series in a fixed protein matrix. J Am Chem Soc (2001) 1.19
Intracellular trafficking of the human immunodeficiency virus type 1 Rev protein: involvement of continued rRNA synthesis in nuclear retention. AIDS Res Hum Retroviruses (1995) 1.19
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol (2006) 1.18
Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I. Proc Natl Acad Sci U S A (1986) 1.16
Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families. Oncogene (1999) 1.14
Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease. J Virol (1997) 1.10
Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome. J Natl Cancer Inst Monogr (2001) 1.09
Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol (1999) 1.09
Pattern of antibody response against the V3 loop in children with vertically acquired immunodeficiency virus type 1 (HIV-1) infection. AIDS Res Hum Retroviruses (1993) 1.09
Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. AIDS (1995) 1.09
Reduced seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV), human herpesvirus 8 (HHV8), related to suppression of Anopheles density in Italy. Med Vet Entomol (2003) 1.08
SPINE bioinformatics and data-management aspects of high-throughput structural biology. Acta Crystallogr D Biol Crystallogr (2006) 1.08
Vertical transmission of HIV-1: lack of detectable virus in peripheral blood cells of infected children at birth. AIDS (1992) 1.07
Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice. J Immunol (1991) 1.06
Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission. AIDS (2000) 1.05
CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. Blood (1995) 1.05
Large genomic deletions inactivate the BRCA2 gene in breast cancer families. J Med Genet (2005) 1.04
Solution structure of oxidized microsomal rabbit cytochrome b5. Factors determining the heterogeneous binding of the heme. Eur J Biochem (2000) 1.03
HIV-1 induces down-regulation of bcl-2 expression and death by apoptosis of EBV-immortalized B cells: a model for a persistent "self-limiting" HIV-1 infection. Virology (1994) 1.02
The solution structure of oxidized Escherichia coli cytochrome b562. Biochemistry (1999) 1.01
Mitochondrial cytochromes c: a comparative analysis. J Biol Inorg Chem (1999) 1.01
Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene. AIDS Res Hum Retroviruses (1999) 1.00
B cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement. J Immunol (1991) 1.00
In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis. AIDS Res Hum Retroviruses (1990) 1.00
Thymus-marrow cell interaction evaluated by PHA stimulation and graft versus host activity. Nature (1971) 1.00
Human T-lymphotropic virus type I transcriptional regulation by methylation. Cancer Res (1990) 1.00
Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosis. J Exp Med (1989) 0.99
Backbone dynamics of human Cu,Zn superoxide dismutase and of its monomeric F50E/G51E/E133Q mutant: the influence of dimerization on mobility and function. Biochemistry (2000) 0.99
Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys. J Gen Virol (1997) 0.98
Inhibition of human T-cell leukemia virus type 2 Rex function by truncated forms of Rex encoded in alternatively spliced mRNAs. J Virol (1997) 0.98
P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. Ann Surg Oncol (2001) 0.96
The p13II protein of HTLV type 1: comparison with mitochondrial proteins coded by other human viruses. AIDS Res Hum Retroviruses (2000) 0.96
Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families. Cancer Res (1996) 0.95
CD4 and CD8 T lymphocyte inheritance. Evidence for major autosomal recessive genes. Hum Genet (1999) 0.95
Paramagnetic relaxation as a tool for solution structure determination: Clostridium pasteurianum ferredoxin as an example. Proteins (1997) 0.94
Unique features of HIV-1 Rev protein phosphorylation by protein kinase CK2 ('casein kinase-2'). FEBS Lett (2000) 0.94
Polymerase chain reaction and in-vitro antibody production for early diagnosis of paediatric HIV infection. Lancet (1988) 0.94
The MHC class I heavy chain is a common target of the small proteins encoded by the 3' end of HTLV type 1 and HTLV type 2. AIDS Res Hum Retroviruses (2000) 0.94
Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage. Br J Haematol (1999) 0.93
Perinatal infection by human immunodeficiency virus type 1 (HIV-1): relationship between proviral copy number in vivo, viral properties in vitro, and clinical outcome. J Med Virol (1991) 0.92
Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection. J Pediatr (1993) 0.92
Transcriptional block of HTLV-I LTR by sequence-specific methylation. Virology (1991) 0.92
Relationship between the V3 loop and the phenotypes of human immunodeficiency virus type 1 (HIV-1) isolates from children perinatally infected with HIV-1. J Virol (1995) 0.92
Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children. J Infect Dis (2001) 0.92
Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome. Eur J Cancer (1999) 0.91
The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth. Cell Death Differ (2005) 0.91
Membrane form of TNF alpha induces both cell lysis and apoptosis in susceptible target cells. Cell Immunol (1996) 0.90
Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach. J Virol (1999) 0.90
Tumours of the haematopoietic system. IARC Sci Publ (1979) 0.90
Phosphorylation of HIV-1 Rev protein: implication of protein kinase CK2 and pro-directed kinases. Biochem Biophys Res Commun (1996) 0.89
HTLV-I/HTLV-II coinfection in an AIDS patient from São Paulo, Brazil. AIDS Res Hum Retroviruses (2000) 0.89
HIV-1 infection of the thymus: evidence for a cytopathic and thymotropic viral variant in vivo. AIDS Res Hum Retroviruses (1995) 0.89
Solution structure calculations through self-orientation in a magnetic field of a cerium(III) substituted calcium-binding protein. J Magn Reson (2001) 0.89
Menkes disease. Cell Mol Life Sci (2008) 0.88
Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells. Gene Ther (2002) 0.88
Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer. Cancer Lett (2001) 0.88
Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells. Gene Ther (1998) 0.88
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. J Urol (2010) 0.88
Frequency of a mutated CCR-5 allele (delta32) among Italian healthy donors and individuals at risk of parenteral HIV infection. AIDS Res Hum Retroviruses (1999) 0.88
Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism. Virology (1991) 0.87
Myosin isoform expression in rat rhabdomyosarcoma induced by Moloney murine sarcoma virus. J Cancer Res Clin Oncol (1987) 0.87
Effect of antiadhesive agents on peritoneal carcinomatosis in an experimental model. Br J Surg (2003) 0.87
B-cell activation during HIV-1 infection. III. Down-regulating effect of mitogens. AIDS (1991) 0.87
Solution structure of reduced microsomal rat cytochrome b5. Eur J Biochem (1997) 0.87
Association of p53 gene and protein alterations with metastases in colorectal cancer. Am J Surg Pathol (1995) 0.87
Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes. Eur J Immunol (1990) 0.87
Age dependence and genetics of expression of ecotropic murine leukemia virus in SJL/J mice. J Natl Cancer Inst (1979) 0.86
Nucleotide sequence and restriction fragment-length polymorphism analysis of human T-cell lymphotropic virus type II (HTLV-II) in southern Europe: evidence for the HTLV-IIa and HTLV-IIb subtypes. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.86
Influence of Rex and intronic sequences on expression of spliced mRNAs produced by human T cell leukemia virus type I. AIDS Res Hum Retroviruses (1999) 0.85
Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma. J Cancer Res Clin Oncol (1994) 0.85
HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil. Eur J Epidemiol (1994) 0.85